Beta Bionics, Inc. (BBNX)
19.42
-0.50
(-2.51%)
USD |
NASDAQ |
Sep 04, 16:00
19.41
-0.01
(-0.05%)
After-Hours: 20:00
Beta Bionics Total Liabilities (Quarterly) : 36.02M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.02M |
| March 31, 2026 | 33.17M |
| December 31, 2025 | 41.13M |
| September 30, 2025 | 35.29M |
| June 30, 2025 | 28.34M |
| March 31, 2025 | 24.27M |
| Date | Value |
|---|---|
| December 31, 2024 | 73.63M |
| September 30, 2024 | 64.07M |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 51.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Enovis Corp. | 2.287B |
| Edwards Lifesciences Corp. | 3.142B |
| Intuitive Surgical, Inc. | 2.579B |
| Kewaunee Scientific Corp. | 101.50M |
| STAAR Surgical Co. | 109.81M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 292.39M |
| Shareholders Equity (Quarterly) | 256.37M |
| Debt to Equity Ratio | 0.0254 |
| Current Ratio | 8.880 |
| Net Debt Paydown Yield | 0.01% |